drugset
Drugs / K-PAX Synergy
last change May 2016 re-read 2 minutes ago

K-PAX Synergy

also known as GWI Nutrient Formula
Developed for
persian gulf syndrome
Investigated by
K-PAX Pharmaceuticals, Inc. · VA Palo Alto Health Care System

Trials 1 · a red edge is where a trial was stopped

today NCT02357030 · Ph 2
2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02357030 Jan 2015 → May 2016 persian gulf syndrome K-PAX Pharmaceuticals, Inc. Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as K-PAX Synergy “methylphenidate (Ritalin®), combined with a GWI Nutrient Formula (K-PAX Synergy) to treat Gulf War Illness (GWI).” NCT02357030 ↗
Known as GWI Nutrient Formula “The Gulf War Synergy Trial will evaluate the safety and efficacy of a currently available medication, methylphenidate (Ritalin®), combined with a GWI Nutrient Formula (K-PAX...” NCT02357030 ↗